Cardiology Search
Cardiology Cardiology
tachycardia
TACHYCARDIA

Tachycardia or tachyarrhythmia is used to describe the presence of cardiac rhythm abnormality in states when cardiac rate is increased to >100 bpm.

Divided into supraventricular and ventricular tachycardia.

Signs and symptoms related to rapid heart rate are altered sensorium, angina, shortness of breath, myocardial infarction, hypotension and other signs of shock (eg cold clammy skin, low urine output), heart failure or pulmonary congestion.

Drug Information

Indication: DVT & pulmonary embolism (PE). Prevention of stroke & systemic embolism in adult patients w/ non-valvu...

Indication: HTN.

Indication: Symptomatic supraventricular tachyarrhythmias requiring treatment eg, AV junctional or supraventricular tachyc...

Dosage: HTN 50-100 mg daily as single dose. Arrhythmia Oral maintenance: 50-100 mg daily as single dose. Angina 50 mg

Indication: HTN; angina pectoris; MI. Disturbances of cardiac rhythm including supraventricular tachycardia. Functional he...

Indication: Essential HTN, angina pectoris. Symptomatic, stable, chronic heart failure.

Indication: Adult patients suffering from MI (few days until <35 days), ischaemic stroke (7 days until <6 mth) or es...

Indication: Prevention of atherothrombotic events in MI (from a few days until <35 days), ischaemic stroke (7 days unti...

Indication: Prevention of artherothrombotic events eg, recent MI, stroke, established peripheral arterial disease; acute c...

Indication: Acute hypomagnesaemia. Prevention of hypomagnesaemia in patients receiving TPN. Prevention & treatment of ...

1  /  7
1  /  7
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Routine STEMI activation in STE-aVR not necessary for emergent revascularization
03 Jun 2019
Only 10 percent of patients in this study show an association between ST elevation (STE) in lead augmented vector right (aVR) with multilead ST depression and acutely thrombotic coronary occlusion. Thus, routine STE myocardial infarction (STEMI) activation in STE-aVR is not required for emergent revascularization, but urgent catheterization appears to be essential.
Baseline severity, sinotubular junction dimension predict progression in aortic regurgitation
30 Nov 2019
A study has shown disease progression in 21 percent of patients with aortic regurgitation (AR) from stage B to stage C/D, and this progression is associated with baseline AR severity and dimensions of sinotubular junction and annulus.
Ischaemic, bleeding risk trade-off different in Asians vs non-Asians
Pearl Toh, 20 Nov 2019
The trade-off between the risk of ischaemic vs bleeding events may be different between Asian and non-Asian patients, which warrants careful consideration when deciding on the duration of antiplatelet therapy following a percutaneous coronary intervention (PCI), according to a presentation at ESC Asia Congress 2019.
SBP variation predicts outcomes in subarachnoid haemorrhage
01 Dec 2019
Variations in systolic blood pressure (SBP) in the first 24 hours after admission appear to be linked to outcomes in patients with acute spontaneous subarachnoid haemorrhage, a recent study has found.